Back to Authors

Liu, Shuzhen

0000-0003-4502-7816

A5027090738 | I141945490

Mayo Clinic

University of British Columbia

Citations 1

Prognostic and predictive significance of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial.

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 11019-11019

10.1200/jco.2014.32.15_suppl.11019